A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

NCT00637247 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

142

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Neoplasms

Interventions

DRUG: imexon in combination with gemcitabine
DRUG: imexon placebo + gemcitabine

Sponsor

AmpliMed Corporation